Dydrogesterone
- Generic Name
- Dydrogesterone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H28O2
- CAS Number
- 152-62-5
- Unique Ingredient Identifier
- 90I02KLE8K
- Background
A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation.
- Indication
Used to treat irregular duration of cycles and irregular occurrence and duration of periods caused by progesterone deficiency. Also used to prevent natural abortion in patients who have a history of habitual abortions.
- Associated Conditions
- Infertility, Menstrual Distress (Dysmenorrhea), Premenstrual Syndrome (PMS), Recurrent Miscarriages, Spontaneous Abortions
- Associated Therapies
- Assisted Reproductive Technology therapy, Menstrual Regulation
Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 716
- Registration Number
- NCT03859921
- Locations
- 🇨🇳
Department of Obstetrics and Gynaecology, Hong Kong, Hong Kong, China
Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)
- First Posted Date
- 2019-02-28
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Merck KGaA, Darmstadt, Germany
- Target Recruit Count
- 172
- Registration Number
- NCT03858049
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Dydrogesterone in the Treatment of Endometrial Polyps
- First Posted Date
- 2018-12-31
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03790215
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
- First Posted Date
- 2018-09-21
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 784
- Registration Number
- NCT03680053
- Locations
- 🇨🇳
ShangHai JIAI Genetics&IVF Institute, Shanghai, China
Non-interventional Study of Therapy for Threatened Miscarriage
- Conditions
- Interventions
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Besins Healthcare
- Target Recruit Count
- 1241
- Registration Number
- NCT03309735
- Locations
- 🇷🇺
Regional perinatal center, Kursk, Kursk Region, Russian Federation
🇷🇺City Clinical Hospital of the Demsk District, Ufa, Bashkortostan Republic, Russian Federation
🇷🇺Сity hospital №7, Samara, Samara Region, Russian Federation
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
- Conditions
- Interventions
- First Posted Date
- 2016-12-13
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Shanghai First Maternity and Infant Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT02990403
- Locations
- 🇨🇳
Shanghai first Maternity and Infant health hospital, Tong Ji University, Shanghai, China
Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
- Conditions
- Interventions
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2017-10-10
- Lead Sponsor
- Sanpasitthiprasong Hospital
- Target Recruit Count
- 231
- Registration Number
- NCT02989519
- Locations
- 🇹🇭
Piyawadee Wuttikonsammakit, Nai Muang, Ubon Ratchathani, Thailand
A Survey on Efficacy and Safety in Patients With Endometriosis
- First Posted Date
- 2016-10-03
- Last Posted Date
- 2022-07-06
- Lead Sponsor
- Mylan Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT02921763
- Locations
- 🇯🇵
Mylan Investigational Site A, Kamigyo-ku, Kyoto, Japan
🇯🇵Mylan Investigational Site D, Saitama, Iwatsukiku, Japan
🇯🇵Mylan Investigational Site E, Kyoto, Ukyouku, Japan
Use of Cyclosporin A for the Treatment of Recurrent Miscarriage
- First Posted Date
- 2016-03-11
- Last Posted Date
- 2016-03-15
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 384
- Registration Number
- NCT02706470
- Locations
- 🇨🇳
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 48
- Registration Number
- NCT02262481
- Locations
- 🇹🇭
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.